Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer

Makoto Tahara,Hironobu Minami,Yoshinori Hasegawa,K. Tomita,A. Watanabe,Ken-ichi Nibu,Masato Fujii,Yusuke Onozawa,Y. Kurono,D. Sagae,Taku Seriu,Mamoru Tsukuda

Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer

2011

Makoto Tahara
Hironobu Minami
Yoshinori Hasegawa
K. Tomita
A. Watanabe
Ken-ichi Nibu
Masato Fujii
Yusuke Onozawa
Y. Kurono
D. Sagae
Taku Seriu
Mamoru Tsukuda

Purpose To evaluate the efficacy and safety of weekly paclitaxel in patients with recurrent or metastatic head and neck cancer (HNC) by combined analysis of early and late phase II trials.

Keywords:

Pharmacology
Paclitaxel
Oncology
Head and neck cancer
Internal medicine
General surgery
Medicine
Carcinoma
Survival analysis
Randomized controlled trial
Clinical trial
Phases of clinical research
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations